Empiric use of amiodarone and sotalol

Matthew Nora, Douglas P. Zipes

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Several studies have demonstrated that class I antiarrhythmic drugs do not reduce, and may increase, sudden cardiac death mortality and total cardiac mortality. Because of this, alternative drug choices for antiarrhythmic therapy are necessary. Amiodarone has been demonstrated to be an important and effective antiarrhythmic agent, as has sotalol. The purpose of this article is to review the various indications and possible benefits of the empiric use of these 2 antiarrhythmic agents.

Original languageEnglish
JournalThe American Journal of Cardiology
Volume72
Issue number16
DOIs
StatePublished - Nov 26 1993

Fingerprint

Sotalol
Amiodarone
Anti-Arrhythmia Agents
Mortality
Sudden Cardiac Death
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Empiric use of amiodarone and sotalol. / Nora, Matthew; Zipes, Douglas P.

In: The American Journal of Cardiology, Vol. 72, No. 16, 26.11.1993.

Research output: Contribution to journalArticle

Nora, Matthew ; Zipes, Douglas P. / Empiric use of amiodarone and sotalol. In: The American Journal of Cardiology. 1993 ; Vol. 72, No. 16.
@article{208603f2ff67445a93e66fd5b78c859e,
title = "Empiric use of amiodarone and sotalol",
abstract = "Several studies have demonstrated that class I antiarrhythmic drugs do not reduce, and may increase, sudden cardiac death mortality and total cardiac mortality. Because of this, alternative drug choices for antiarrhythmic therapy are necessary. Amiodarone has been demonstrated to be an important and effective antiarrhythmic agent, as has sotalol. The purpose of this article is to review the various indications and possible benefits of the empiric use of these 2 antiarrhythmic agents.",
author = "Matthew Nora and Zipes, {Douglas P.}",
year = "1993",
month = "11",
day = "26",
doi = "10.1016/0002-9149(93)90965-F",
language = "English",
volume = "72",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "16",

}

TY - JOUR

T1 - Empiric use of amiodarone and sotalol

AU - Nora, Matthew

AU - Zipes, Douglas P.

PY - 1993/11/26

Y1 - 1993/11/26

N2 - Several studies have demonstrated that class I antiarrhythmic drugs do not reduce, and may increase, sudden cardiac death mortality and total cardiac mortality. Because of this, alternative drug choices for antiarrhythmic therapy are necessary. Amiodarone has been demonstrated to be an important and effective antiarrhythmic agent, as has sotalol. The purpose of this article is to review the various indications and possible benefits of the empiric use of these 2 antiarrhythmic agents.

AB - Several studies have demonstrated that class I antiarrhythmic drugs do not reduce, and may increase, sudden cardiac death mortality and total cardiac mortality. Because of this, alternative drug choices for antiarrhythmic therapy are necessary. Amiodarone has been demonstrated to be an important and effective antiarrhythmic agent, as has sotalol. The purpose of this article is to review the various indications and possible benefits of the empiric use of these 2 antiarrhythmic agents.

UR - http://www.scopus.com/inward/record.url?scp=0027495511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027495511&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(93)90965-F

DO - 10.1016/0002-9149(93)90965-F

M3 - Article

C2 - 8237832

AN - SCOPUS:0027495511

VL - 72

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 16

ER -